Home

Vivo Capital Fund VIII, L.P.

CIK 1618788 · last filed 2022-08-16

Vivo Capital Fund VIII, L.P. is a corporate insider who has filed 6 SEC Form 4 insider transactions across 5 companies since 2017. The most recent filing shows the insider bought $34.9M of TERN on Aug 16, 2022. Across all open-market trades the lifetime net is +$104.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $84.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$84.74M

Companies

5

Total Filings

6

Lifetime Open-Market Net

$104.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Terns Pharmaceuticals, Inc. (TERN) Delisted 10%+ Owner 281,223 $52.95 $14.89M $75.28M 2 2022-08-16
IPI Legacy Liquidation Co (IMPL) Delisted 10%+ Owner 1,625,022 $0.24 $391.8K $25.88M 1 2021-04-29
CRNX 10%+ Owner 2,458,445 $34.47 $84.74M -$12.68M 1 2020-04-07
VYNE Therapeutics Inc. (MNLO) Delisted 10%+ Owner 3,524,541 — — $15.00M 1 2018-01-29
Timber Pharmaceuticals, Inc. (BPMX) Delisted 10%+ Owner 14,096,338 — — $1.00M 1 2017-05-01

Recent Filings

6 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-08-16 Terns Pharmaceuticals, Inc. (TERN) Delisted Buy (P) +13,121,195 $34.90M EDGAR
2021-04-29 IPI Legacy Liquidation Co (IMPL) Delisted Mixed +8,654,367 $29.98M EDGAR
2021-02-09 Terns Pharmaceuticals, Inc. (TERN) Delisted Mixed +13,375,665 $40.38M EDGAR
2020-04-07 CRNX Sell (S) −918,345 -$12.68M EDGAR
2018-01-29 VYNE Therapeutics Inc. (MNLO) Delisted Mixed +12,033,708 $15.00M EDGAR
2017-05-01 Timber Pharmaceuticals, Inc. (BPMX) Delisted Buy (P) +1,282,052 $1.00M EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.